|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | Bal, 2,3-Dimercapto-1-propanol, Dithioglycerol | Storage (From the date of receipt) |
2 years -20°C liquid |
| 化学式 | C3H8OS2 |
|||
| 分子量 | 124.22 | CAS No. | 59-52-9 | |
| Solubility (25°C)* | 体外 | |||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
||||
| 製品説明 | Dimercaprol (Bal、2,3-ジメルカプト-1-プロパノール、ジチオグリセロール) は、インビトロでHIV-1 tat活性、ウイルス産生、および感染性を阻害するアクロレイン捕捉剤です。 | |||||
|---|---|---|---|---|---|---|
| in vitro | Dimercaprol exerts its acrolein scavenging capability, significantly protects PC-12 cells from acrolein-mediated cell death in a dose dependent manner. |
|||||
| in vivo | Dimercaprol could significantly reduce acrolein contents in spinal cord tissue following a spinal cord contusion injury in rats. |
|||||
| 密度 | 1.239 g/mL | |||||
| 細胞アッセイ | 細胞株 | PC-12 cells |
|---|---|---|
| 濃度 | 10, 25, 50 and 100 μM | |
| 反応時間 | 4 h | |
| 実験の流れ | Cell viability was tested by WST-1 ([2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium]) assay. Both dimercaprol and acrolein were dissolved in Hank’s Balanced Salt Solution (HBSS). The final concentration of acrolein was 100 μM. The final concentrations of dimercaprol were 10, 25, 50 and 100 μM. PC-12 cells were seeded in 12-well plates at the concentration of 105 cells/well. After overnight incubation, acrolein was added into each well of acrolein group and treatment groups. Equal volumes of HBSS were added into wells of the negative control group. After incubation for 15 minutes, dimercaprol was added at the desired final concentrations (10, 25, 50 and 100 μM) into wells of treatment groups and equal volume of HBSS was added into other wells. The initial 15-minute incubation in acrolein was designed to mimic pathological conditions by allowing acrolein to enter the cells. WST-1 assay solution was added into every well after incubating 4 h, and then allowed to incubate for an additional 2 h. |
|
| 動物実験 | 動物モデル | Male Sprague–Dawley rats of spinal cord contusion injury model |
| 投薬量 | 5 mg/kg | |
| 投与方法 | i.p |
|
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。